By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Anthera Pharmaceuticals, Inc. 

25801 Industrial Boulevard
Suite B
Hayward  California  94545  U.S.A.
Phone: 510-856–5600 Fax: 510-856–5597


SEARCH JOBS


Industry
Pharmaceutical






Company News
Anthera Pharma (ANTH) Announces RESULT Phase III Clinical Study Of Sollpura Will Be Included In The Cystic Fibrosis Foundation Therapeutics Development Network 7/10/2017 8:26:45 AM
Anthera Pharma (ANTH) Plunges After Cystic Fibrosis Drug Fails Late-Stage Trial 12/28/2016 7:11:07 AM
Anthera Pharma (ANTH) Provides Business Update And Reports 2016 Third Quarter Financial Results 11/4/2016 8:26:10 AM
Anthera Pharma (ANTH)Announces Completion Of Dosing In CHABLIS-SC1 Phase III Clinical Study With Blisibimod 8/4/2016 8:02:49 AM
Anthera Pharma (ANTH) Provides Business Update And Reports 2015 Fourth Quarter And Fiscal Year Financial Results 3/10/2016 8:18:20 AM
Anthera (ANTH) Shares Slump as Zenyaku Kogyo Backs Out of Blisibimod Deal 9/15/2015 6:42:21 AM
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2015 Second Quarter And Operational Update 8/11/2015 12:27:43 PM
Anthera Pharmaceuticals, Inc. (ANTH) To Report 2015 Second Quarter And Operational Update On August 10 7/31/2015 7:10:48 AM
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 7/14/2015 1:24:08 PM
Anthera Pharmaceuticals, Inc. (ANTH) Announces Pricing Of Public Offering Of Common Stock 7/9/2015 7:24:49 AM
12345678910...
//-->